Marco Stellato

15PUBLICATIONS

40CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityCancer geneticsPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (15)

Sort by Publication Date:

|Jun 10, 2026

Local treatment of the primary tumor in mHSPC in the ARPI era: incremental value or overtreatment?

|May 06, 2026

<sup>177</sup>Lu-PSMA-617 radioligand therapy as an immune modulator in prostate cancer.

|Jan 10, 2026

An update on the treatment paradigm for non-clear cell renal cell carcinoma.

Alessandro Rametta, Noemi Crippa, Simone Rota

|Aug 29, 2025

Marco Stellato, Ernesto Zecca, Paola Bracchi

|Aug 18, 2025

Targeting Cyclin-Dependent Kinase 4 Amplifications: A Pioneering Case of Metastatic Leydig Cell Tumor Responding to Abemaciclib.

Amedeo Nuzzo, Marco Barella, Melanie Claps

|Oct 19, 2023

Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian Experts.

Daniele Santini, Giuseppe Luigi Banna, Sebastiano Buti

Pageof 3

Frequent Collaborators

Sebastiano Buti

Alessandro Rametta

Giuseppe Procopio

Giuseppe Luigi Banna

Ugo De Giorgi

Melissa Bersanelli

Andrea Necchi

Simone Rota

Marco Maruzzo

Alessia Cavo

Frequent Collaborators

Sebastiano Buti

Alessandro Rametta

Giuseppe Procopio

Giuseppe Luigi Banna